BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21859851)

  • 1. Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17).
    Hung CY; Gonzalez A; Wüthrich M; Klein BS; Cole GT
    Infect Immun; 2011 Nov; 79(11):4511-22. PubMed ID: 21859851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
    Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
    Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
    Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
    Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection.
    Hung CY; Wozniak KL; Cole GT
    Methods Mol Biol; 2016; 1403():551-66. PubMed ID: 27076153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinated C57BL/6 mice develop protective and memory T cell responses to Coccidioides posadasii infection in the absence of interleukin-10.
    Hung CY; Castro-Lopez N; Cole GT
    Infect Immun; 2014 Feb; 82(2):903-13. PubMed ID: 24478103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against
    Campuzano A; Zhang H; Ostroff GR; Dos Santos Dias L; Wüthrich M; Klein BS; Yu JJ; Lara HH; Lopez-Ribot JL; Hung CY
    J Immunol; 2020 Jun; 204(12):3296-3306. PubMed ID: 32358020
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin-1 receptor but not Toll-like receptor 2 is essential for MyD88-dependent Th17 immunity to Coccidioides infection.
    Hung CY; Jiménez-Alzate Mdel P; Gonzalez A; Wüthrich M; Klein BS; Cole GT
    Infect Immun; 2014 May; 82(5):2106-14. PubMed ID: 24614655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
    Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
    Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
    Xue J; Hung CY; Yu JJ; Cole GT
    Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.
    Hurtgen BJ; Hung CY; Ostroff GR; Levitz SM; Cole GT
    Infect Immun; 2012 Nov; 80(11):3960-74. PubMed ID: 22949556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
    Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
    Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Card9- and MyD88-Mediated Gamma Interferon and Nitric Oxide Production Is Essential for Resistance to Subcutaneous Coccidioides posadasii Infection.
    Hung CY; Castro-Lopez N; Cole GT
    Infect Immun; 2016 Apr; 84(4):1166-75. PubMed ID: 26857574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dectin-1 is required for resistance to coccidioidomycosis in mice.
    Viriyakosol S; Jimenez Mdel P; Gurney MA; Ashbaugh ME; Fierer J
    mBio; 2013 Feb; 4(1):e00597-12. PubMed ID: 23386437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection.
    Hung CY; Zhang H; Castro-Lopez N; Ostroff GR; Khoshlenar P; Abraham A; Cole GT; Negron A; Forsthuber T; Peng T; Galgiani JN; Ampel NM; Yu JJ
    Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30104216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of phagocyte NADPH oxidase 2 leads to severe inflammatory response in lungs of mice infected with Coccidioides.
    Gonzalez A; Hung CY; Cole GT
    Microb Pathog; 2011 Dec; 51(6):432-41. PubMed ID: 21896326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-type lectin receptors differentially induce th17 cells and vaccine immunity to the endemic mycosis of North America.
    Wang H; LeBert V; Hung CY; Galles K; Saijo S; Lin X; Cole GT; Klein BS; Wüthrich M
    J Immunol; 2014 Feb; 192(3):1107-1119. PubMed ID: 24391211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
    Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
    Herr RA; Hung CY; Cole GT
    Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
    Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
    Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice.
    Fierer J; Waters C; Walls L
    J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.